1 / 2

Mounjaro Lawsuits 2024: The Background Story

It is the responsibility of drug manufacturers to alert users and/or prescribing physicians to any risks related to the specific product. Mounjaro stomach paralysis lawsuits are on the boom for the dangerous side effects of this diabetic medication.

Edwina4
Download Presentation

Mounjaro Lawsuits 2024: The Background Story

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mounjaro Lawsuits 2024: Mounjaro Lawsuits 2024: The Background The Background Story Story It is the responsibility of drug manufacturers to alert users and/or prescribing physicians to any risks related to the specific product. Mounjaro stomach paralysis lawsuits are on the boom for the dangerous side effects of this diabetic medication. Mounjaro stomach paralysis lawsuits is related with Mounjaro, a gastric inhibitory polypeptide (GIP) as well as a dual agonist of the glucagon-like peptide 1 (GLP-1) receptor. With 39 amino acids, it is an analogue of the gastric inhibitory polypeptide. Mounjaro works by encouraging the pancreas to release more insulin, which lowers hyperglycemia. This injection can be used by adults with type 2 diabetes to lower their A1C and blood glucose levels. By assisting the pancreas in producing more insulin, reducing the quantity of sugar your liver produces, and slowing down the rate at which food enters your body, Mount Kilimanjaro lowers blood sugar levels. https://www.lezdotechmed.com/

  2. It decreases glucagon levels and increases both first- and second-phase insulin secretion in a glucose-dependent manner. In August 2023, the first Mounjaro lawsuit for stomach paralysis was filed. It concerned Ozempic, another well-known weight-loss drug that is also being sued. The plaintiff in the lawsuit claimed to have severe paralysis of the stomach. Blake, a diabetic man of 38 years old, filed a second lawsuit after taking two doses of Mounjaro. The delayed emptying of the stomach brought on by Mounjaro keeps the food that has been digested inside the stomach. A pause in the regular digestive process can cause severe symptoms that impact the body's metabolism and overall health. Eli Lilly and Company have, like in any other product liability case, disclaimed any responsibility, maintained the safety of their medications, and committed to putting an end to the lawsuit. An estimated 10,000 Mounjaro lawsuits are pending investigation and are part of the process to combine cases for pretrial proceedings in federal court in Louisiana. https://www.lezdotechmed.com/

More Related